← Open Payments lookup

GRAYSON GRANT: Open Payments

NPI 1164098216 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,074 in 124 payments from 21 companies in 2025. Trend: 2023 $2,519 · 2024 $2,016 · 2025 $2,074

Food & beverage: $2,074
CompanyPaymentsAmount
ABBVIE INC.35$423
Janssen Biotech, Inc.16$320
Salix Pharmaceuticals, a division of Bausch Health US, LLC18$303
Madrigal Pharmaceuticals11$178
Ardelyx, Inc.6$107
Janssen Scientific Affairs, LLC1$90
Takeda Pharmaceuticals U.S.A., Inc.5$90
Lilly USA, LLC4$70
Aimmune Therapeutics, Inc.4$68
Regeneron Healthcare Solutions, Inc.2$64

Products named: TREMFYA, XIFAXAN, REZDIFFRA, LINZESS, RINVOQ, DUPIXENT, IBSRELA, RELISTOR.

Industry payments across AR — which companies pay providers there.